AbClon
AbClon is a South Korean biotech company founded in 2010 that develops advanced cell and gene therapy platforms and antibody drug technologies.
Last updated September 16, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
AbClon (앱클론(주)) is a biotechnology company based in Seoul, South Korea. According to its official website, it was founded in 2010 by a group of Korean and Swedish scientists and holds technology for developing advanced cell and gene therapy platforms to treat various cancers, positioning itself as a frontrunner in antibody drug development.
History
AbClon was founded in 2010 by a group of Korean and Swedish scientists. The company is based in Seoul, South Korea, and develops advanced cell and gene therapy platforms for treating various cancers, with a stated position as a frontrunner in antibody drug development.
Products and positioning
Frontrunner in antibody drug development with advanced cell and gene therapy platforms for cancer treatment
Sources1 sources
Cite this profile: Cite the canonical profile. /brand-wiki/abclon-korea · Editorial policy · How profiles are compiled